» Articles » PMID: 33674893

3D Voxel-based Dosimetry to Predict Contralateral Hypertrophy and an Adequate Future Liver Remnant After Lobar Radioembolization

Overview
Date 2021 Mar 6
PMID 33674893
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Volume changes induced by selective internal radiation therapy (SIRT) may increase the possibility of tumor resection in patients with insufficient future liver remnant (FLR). The aim was to identify dosimetric and clinical parameters associated with contralateral hepatic hypertrophy after lobar/extended lobar SIRT with Y-resin microspheres.

Materials And Methods: Patients underwent Y PET/CT after lobar or extended lobar (right + segment IV) SIRT. Y voxel dosimetry was retrospectively performed (PLANET Dose; DOSIsoft SA). Mean absorbed doses to tumoral/non-tumoral-treated volumes (NTL) and dose-volume histograms were extracted. Clinical variables were collected. Patients were stratified by FLR at baseline (T0-FLR): < 30% (would require hypertrophy) and ≥ 30%. Changes in volume of the treated, non-treated liver, and FLR were calculated at < 2 (T1), 2-5 (T2), and 6-12 months (T3) post-SIRT. Univariable and multivariable regression analyses were performed to identify predictors of atrophy, hypertrophy, and increase in FLR. The best cut-off value to predict an increase of FLR to ≥ 40% was defined using ROC analysis.

Results: Fifty-six patients were studied; most had primary liver tumors (71.4%), 40.4% had cirrhosis, and 39.3% had been previously treated with chemotherapy. FLR in patients with T0-FLR < 30% increased progressively (T0: 25.2%; T1: 32.7%; T2: 38.1%; T3: 44.7%). No dosimetric parameter predicted atrophy. Both NTL-Dmean and NTL-V30 (fraction of NTL exposed to ≥ 30 Gy) were predictive of increase in FLR in patients with T0 FLR < 30%, the latter also in the total cohort of patients. Hypertrophy was not significantly associated with tumor dose or tumor size. When ≥ 49% of NTL received ≥ 30 Gy, FLR increased to ≥ 40% (accuracy: 76.4% in all patients and 80.95% in T0-FLR < 30% patients).

Conclusion: NTL-Dmean and NTL exposed to ≥ 30 Gy (NTL-V30) were most significantly associated with increase in FLR (particularly among patients with T0-FLR < 30%). When half of NTL received ≥ 30 Gy, FLR increased to ≥ 40%, with higher accuracy among patients with T0-FLR < 30%.

Citing Articles

Prediction of left lobe hypertrophy with voxel-based dosimetry using integrated Y-90 PET/MRI after radioembolization of liver tumors with Y-90 microspheres.

Demir B, Soydal C, Celebioglu E, Bilgic M, Kuru Oz D, Kir K Eur J Nucl Med Mol Imaging. 2024; .

PMID: 39688696 DOI: 10.1007/s00259-024-07023-y.


Anatomical Quantitative Volumetric Evaluation of Liver Segments in Hepatocellular Carcinoma Patients Treated with Selective Internal Radiation Therapy: Key Parameters Influencing Untreated Liver Hypertrophy.

Girardet R, Knebel J, Dromain C, Violi N, Tsoumakidou G, Villard N Cancers (Basel). 2024; 16(3).

PMID: 38339337 PMC: 10854872. DOI: 10.3390/cancers16030586.


Portal hypertension increases the risk of hepatic decompensation after 90Yttrium radioembolization in patients with hepatocellular carcinoma: a cohort study.

Carrion L, Clemente-Sanchez A, Marquez-Perez L, Orcajo-Rincon J, Rotger A, Ramon-Botella E Therap Adv Gastroenterol. 2023; 16:17562848231206995.

PMID: 37920686 PMC: 10619355. DOI: 10.1177/17562848231206995.


Liver Resection and Transplantation Following Yttrium-90 Radioembolization for Primary Malignant Liver Tumors: A 15-Year Single-Center Experience.

Aliseda D, Marti-Cruchaga P, Zozaya G, Rodriguez-Fraile M, Bilbao J, Benito-Boillos A Cancers (Basel). 2023; 15(3).

PMID: 36765691 PMC: 9913597. DOI: 10.3390/cancers15030733.


Maximum tumor-absorbed dose measured by voxel-based multicompartmental dosimetry as a response predictor in yttrium-90 radiation segmentectomy for hepatocellular carcinoma.

Orcajo Rincon J, Regi A, Pena A, Berenguer L, Leyte M, Martin L EJNMMI Phys. 2023; 10(1):7.

PMID: 36745227 PMC: 9902576. DOI: 10.1186/s40658-022-00520-9.


References
1.
Hemming A, Reed A, Howard R, Fujita S, Hochwald S, Caridi J . Preoperative portal vein embolization for extended hepatectomy. Ann Surg. 2003; 237(5):686-91; discussion 691-3. PMC: 1514515. DOI: 10.1097/01.SLA.0000065265.16728.C0. View

2.
Chiesa C, Maccauro M, Romito R, Spreafico C, Pellizzari S, Negri A . Need, feasibility and convenience of dosimetric treatment planning in liver selective internal radiation therapy with (90)Y microspheres: the experience of the National Tumor Institute of Milan. Q J Nucl Med Mol Imaging. 2011; 55(2):168-97. View